These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35751395)

  • 1. Prognostic importance of improving hepatorenal function during hospitalization in acute decompensated heart failure.
    Mizobuchi S; Saito Y; Fujito H; Miyagawa M; Kitano D; Toyama K; Fukamachi D; Okumura Y
    ESC Heart Fail; 2022 Oct; 9(5):3113-3123. PubMed ID: 35751395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure.
    Kawahira M; Tamaki S; Yamada T; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Nakamura J; Kayama K; Kimura T; Ueda K; Sakamoto D; Kogame T; Ito S; Chang Y; Fukunami M
    ESC Heart Fail; 2021 Apr; 8(2):1274-1283. PubMed ID: 33472273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
    Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the MELD-XI score in patients undergoing cardiac resynchronization therapy.
    Saito Y; Nakai T; Ikeya Y; Kogawa R; Otsuka N; Wakamatsu Y; Kurokawa S; Ohkubo K; Nagashima K; Okumura Y
    ESC Heart Fail; 2022 Apr; 9(2):1080-1089. PubMed ID: 34983080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
    Biegus J; Zymliński R; Sokolski M; Siwołowski P; Gajewski P; Nawrocka-Millward S; Poniewierka E; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2016 Dec; 18(12):1518-1521. PubMed ID: 27709804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of pulmonary arterial wedge pressure estimated by deep learning in acute heart failure.
    Saito Y; Omae Y; Mizobuchi S; Fujito H; Miyagawa M; Kitano D; Toyama K; Fukamachi D; Toyotani J; Okumura Y
    ESC Heart Fail; 2023 Apr; 10(2):1103-1113. PubMed ID: 36583242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair.
    Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Horn P; Sugiura A; Baldus S; Kelm M; Nickenig G; Pfister R; Westenfeld R; Becher MU
    Clin Res Cardiol; 2021 Dec; 110(12):1947-1956. PubMed ID: 34254179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
    Konno R; Tatebe S; Sugimura K; Satoh K; Aoki T; Miura M; Suzuki H; Yamamoto S; Sato H; Terui Y; Miyata S; Adachi O; Kimura M; Saiki Y; Shimokawa H
    PLoS One; 2019; 14(11):e0225403. PubMed ID: 31743362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    Noda T; Kamiya K; Hamazaki N; Nozaki K; Ichikawa T; Yamashita M; Uchida S; Maekawa E; Terada T; Reed JL; Yamaoka-Tojo M; Matsunaga A; Ako J
    J Cardiol; 2023 Feb; 81(2):215-221. PubMed ID: 36167755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
    PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial.
    Biegus J; Demissei B; Postmus D; Cotter G; Davison BA; Felker GM; Filippatos G; Gimpelewicz C; Greenberg B; Metra M; Severin T; Teerlink JR; Voors AA; Ponikowski P
    ESC Heart Fail; 2019 Dec; 6(6):1188-1198. PubMed ID: 31568696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the United Network for Organ Sharing.
    Deo SV; Al-Kindi SG; Altarabsheh SE; Hang D; Kumar S; Ginwalla MB; ElAmm CA; Sareyyupoglu B; Medalion B; Oliveira GH; Park SJ
    J Heart Lung Transplant; 2016 Feb; 35(2):222-7. PubMed ID: 26527533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.
    Chen Y; Liu YX; Seto WK; Wu MZ; Yu YJ; Lam YM; Au WK; Chan D; Sit KY; Ho LM; Tse HF; Yiu KH
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.
    Kim MS; Kato TS; Farr M; Wu C; Givens RC; Collado E; Mancini DM; Schulze PC
    J Am Coll Cardiol; 2013 Jun; 61(22):2253-2261. PubMed ID: 23563127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of modified MELD scores for postdischarge prognosis in hospitalized patients with heart failure.
    Gotou M; Suzuki A; Shiga T; Kikuchi N; Hagiwara N
    Heart Vessels; 2023 Apr; 38(4):535-542. PubMed ID: 36422651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.
    Egbe AC; Miranda WR; Dearani J; Kamath PS; Connolly HM
    J Am Coll Cardiol; 2020 Dec; 76(25):2968-2976. PubMed ID: 33334426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
    Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.